Abstract
This chapter provides answers to practice-based questions with case studies covering the new principles of diagnosis, classification, staging, treatment, and outcomes in the rapidly advancing field of recurrent and metastatic non-small cell lung cancer. Lung cancer remains the leading cause of cancer related deaths worldwide. The number of new lung cancer cases and lung cancer–related deaths continues to decrease each year due to improved smoking cessation rates and implementation of lung cancer screening programs as well as substantial therapeutic advances. Immunotherapy has revolutionized treatment for patients with recurrent and metastatic non-small cell lung cancer without actionable mutations. The chapter also provides expert guidance in the areas of cancer-related uncertainties and controversies, including experience-based discussions.
Original language | English |
---|---|
Title of host publication | Cancer Consult |
Subtitle of host publication | Expertise in Clinical Practice, Volume 1: Solid Tumors and Supportive Care |
Publisher | wiley |
Pages | 79-96 |
Number of pages | 18 |
Volume | 1 |
ISBN (Electronic) | 9781119823766 |
ISBN (Print) | 9781119823735 |
DOIs | |
State | Published - Jan 1 2023 |
Keywords
- Immunotherapy
- Lung cancer screening programs
- Lung cancer–related deaths
- Non-small cell lung cancer